Literature DB >> 27898065

Diagnosis: Improved diagnosis, therapy and outcomes for patients with CUP.

F Anthony Greco1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27898065     DOI： 10.1038/nrclinonc.2016.194

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.

Authors:  John D Hainsworth; Catherine A Schnabel; Mark G Erlander; David W Haines; F Anthony Greco
Journal:  Clin Colorectal Cancer       Date:  2011-10-14       Impact factor: 4.481

2.  Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay.

Authors:  F Anthony Greco; Wayne J Lennington; David R Spigel; John D Hainsworth
Journal:  Mol Diagn Ther       Date:  2015-04       Impact factor: 4.074

Review 3.  Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.

Authors:  John D Hainsworth; F Anthony Greco
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

4.  Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.

Authors:  John D Hainsworth; Mark S Rubin; David R Spigel; Ralph V Boccia; Samuel Raby; Raven Quinn; F Anthony Greco
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

5.  Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.

Authors:  Sebastian Moran; Anna Martínez-Cardús; Sergi Sayols; Eva Musulén; Carme Balañá; Anna Estival-Gonzalez; Cátia Moutinho; Holger Heyn; Angel Diaz-Lagares; Manuel Castro de Moura; Giulia M Stella; Paolo M Comoglio; Maria Ruiz-Miró; Xavier Matias-Guiu; Roberto Pazo-Cid; Antonio Antón; Rafael Lopez-Lopez; Gemma Soler; Federico Longo; Isabel Guerra; Sara Fernandez; Yassen Assenov; Christoph Plass; Rafael Morales; Joan Carles; David Bowtell; Linda Mileshkin; Daniela Sia; Richard Tothill; Josep Tabernero; Josep M Llovet; Manel Esteller
Journal:  Lancet Oncol       Date:  2016-08-27       Impact factor: 41.316

6.  Occult primary, version 3.2014.

Authors:  David S Ettinger; Charles R Handorf; Mark Agulnik; Daniel W Bowles; Justin M Cates; Mihaela Cristea; Efrat Dotan; Keith D Eaton; Panagiotis M Fidias; David Gierada; G Weldon Gilcrease; Kelly Godby; Renuka Iyer; Renato Lenzi; John Phay; Asif Rashid; Leonard Saltz; Richard B Schwab; Lawrence N Shulman; Jeffrey B Smerage; Marvaretta M Stevenson; Gauri R Varadhachary; Jonathan S Zager; Weining Ken Zhen; Mary Anne Bergman; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-07       Impact factor: 11.908

7.  Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset.

Authors:  G R Varadhachary; S Karanth; W Qiao; H R Carlson; M N Raber; J D Hainsworth; F A Greco
Journal:  Int J Clin Oncol       Date:  2013-06-28       Impact factor: 3.402

8.  Switching benchmarks in cancer of unknown primary: from autopsy to microarray.

Authors:  George Pentheroudakis; Vassilios Golfinopoulos; Nicholas Pavlidis
Journal:  Eur J Cancer       Date:  2007-08-14       Impact factor: 9.162

9.  Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.

Authors:  F Anthony Greco; Wayne J Lennington; David R Spigel; John D Hainsworth
Journal:  J Natl Cancer Inst       Date:  2013-05-02       Impact factor: 13.506

10.  Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance).

Authors:  H H Yoon; N R Foster; J P Meyers; P D Steen; D W Visscher; R Pillai; D M Prow; C M Reynolds; B T Marchello; R B Mowat; B I Mattar; C Erlichman; M P Goetz
Journal:  Ann Oncol       Date:  2015-11-16       Impact factor: 32.976
  10 in total
  3 in total

1.  Prognostic factors among patients with brain metastases from cancer of unknown primary site.

Authors:  C Simões Padilla; V K Y Ho; I H van der Strate; W P J Leenders; F Y F L de Vos; S E M Veldhuijzen van Zanten; C Loef
Journal:  J Neurooncol       Date:  2022-08-17       Impact factor: 4.506

Review 2.  Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary.

Authors:  Sebastián Moran; Anna Martinez-Cardús; Stergios Boussios; Manel Esteller
Journal:  Nat Rev Clin Oncol       Date:  2017-07-04       Impact factor: 66.675

Review 3.  Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.

Authors:  Janick Selves; Elodie Long-Mira; Marie-Christine Mathieu; Philippe Rochaix; Marius Ilié
Journal:  Cancers (Basel)       Date:  2018-04-05       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.